M&A Deal Summary

GSK Acquires SmithKline Beecham

On January 17, 2000, GSK acquired life science company SmithKline Beecham for 75.7B USD

Acquisition Highlights
  • This is GSK’s 2nd transaction in the Life Science sector.
  • This is GSK’s largest (disclosed) transaction.
  • This is GSK’s 1st transaction in the United Kingdom.

M&A Deal Summary
Date 2000-01-17
Target SmithKline Beecham
Sector Life Science
Buyer(s) GSK
Deal Type Merger
Deal Value 75.7B USD

Target

SmithKline Beecham

Brentford, United Kingdom
SmithKline Beecham is a global pharmaceutical company based in Brentford, England.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

GSK

Brentford, United Kingdom
Category Company
Founded 1715
Sector Life Science
Employees70,212
Revenue 30.3B GBP (2023)
DESCRIPTION
Entrance to a GlaxoSmithKline facility in Morristown, New Jersey.
Entrance to a GlaxoSmithKline facility in Morristown, New Jersey.

GSK is a multinational pharmaceutical, biologics, vaccines and consumer healthcare company. GSK was founded in 1715 and is based in Brentford, United Kingdom.

DEAL STATS #
Overall 3 of 32
Sector (Life Science) 2 of 26
Type (Merger) 1 of 1
Country (United Kingdom) 1 of 4
Year (2000) 1 of 1
Size (of disclosed) 1 of 28
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
1999-02-09 Diversified Pharmaceutical Services

St. Louis, Montana, United States

Diversified Pharmaceutical Services, Inc.is a provider of pharmaceutical benefit management services.

Sell $700M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2001-01-16 Block Drug Company

Jersey City, New Jersey, United States

Block Drug Company is a pharmaceutical company specializing in dental care products.

Buy $1.2B
Mergr

Product

Company

Legal